MLchartDataset catalogue

ADE

Term · Oncology and biomedicine · MLC-T-ONC-000233

An abbreviation for a chemotherapy combination used to treat childhood acute myeloid leukemia (AML). It includes the drugs cytarabine (Ara-C), daunorubicin hydrochloride, and etoposide phosphate. Also called ADE regimen.

Table 1. Record
IdentifierMLC-T-ONC-000233
FieldOncology and biomedicine
ExpansionsADE regimen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000233",
  "term": "ADE",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat childhood acute myeloid leukemia (AML). It includes the drugs cytarabine (Ara-C), daunorubicin hydrochloride, and etoposide phosphate. Also called ADE regimen.",
  "expansions": [
    "ADE regimen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ade/"
}

Record 377 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.